ClinicalTrials.Veeva

Menu

Association Between Prolactin Levels in Pregnant Women in COVID-19. Gether With Rates of Breastfeeding and the Covid-19 Virus

U

Universidad Católica de Ávila

Status

Completed

Conditions

Breastfeeding
COVID-19 Infection

Treatments

Procedure: blood prolactin levels

Study type

Observational

Funder types

Other

Identifiers

NCT05506280
16/08/22

Details and patient eligibility

About

Background: Currently in the world, 41% of children under 6 months are exclusively breastfed. The Covid-19 pandemic has had a major impact on breastfeeding.; Methods: A statistical analysis of linear regression, prolactin analysis in the 3rd trimester of pregnancy and 15 days 15 after delivery was performed in women with Covid- 19 infection and healthy, finally the rates of 16 breastfeeding were evaluated. The sample was made up of 680 pregnant women from the Valladolid 17 Health Area, central region of Spain.

Enrollment

720 patients

Sex

Female

Ages

16 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women under the coding of the clinical process of normal pregnancy or diagnosis of Covid-19 infection

Exclusion criteria

  • No informed consent.
  • No pregnant women.
  • Older than 50 years old.
  • Younger than 16 years old.

Trial design

720 participants in 1 patient group

Pregnant women
Description:
pregnant women infected by Covid-19
Treatment:
Procedure: blood prolactin levels

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems